TNX-102 2.8 mg sublingual tablet
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TNX-102 2.8 mg sublingual tablet, covering 2014-09-26 to 2014-09-26. Get the full timeline:
Most recent: Clinical Trial Update: Comparative Pharmacokinetics and Safety of 3 Different Formulations of TNX-102 2.8 mg SL Tablets and Cyclobenzaprine 5 mg Oral Tablet in Healthy Adults [Phase 1]